GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) » Definitions » Days Payable

GlaxoSmithKline Pharmaceuticals (BOM:500660) Days Payable : 126.13 (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals Days Payable?

GlaxoSmithKline Pharmaceuticals's average Accounts Payable for the three months ended in Mar. 2024 was ₹6,254 Mil. GlaxoSmithKline Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2024 was ₹4,524 Mil. Hence, GlaxoSmithKline Pharmaceuticals's Days Payable for the three months ended in Mar. 2024 was 126.13.

The historical rank and industry rank for GlaxoSmithKline Pharmaceuticals's Days Payable or its related term are showing as below:

BOM:500660' s Days Payable Range Over the Past 10 Years
Min: 74.72   Med: 112.28   Max: 138.49
Current: 138.49

During the past 13 years, GlaxoSmithKline Pharmaceuticals's highest Days Payable was 138.49. The lowest was 74.72. And the median was 112.28.

BOM:500660's Days Payable is ranked better than
72.02% of 972 companies
in the Drug Manufacturers industry
Industry Median: 89.36 vs BOM:500660: 138.49

GlaxoSmithKline Pharmaceuticals's Days Payable increased from Mar. 2023 (93.24) to Mar. 2024 (126.13). It may suggest that GlaxoSmithKline Pharmaceuticals delayed paying its suppliers.


GlaxoSmithKline Pharmaceuticals Days Payable Historical Data

The historical data trend for GlaxoSmithKline Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pharmaceuticals Days Payable Chart

GlaxoSmithKline Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99.69 112.28 131.61 135.27 135.37

GlaxoSmithKline Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 93.24 131.82 144.94 162.14 126.13

Competitive Comparison of GlaxoSmithKline Pharmaceuticals's Days Payable

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Pharmaceuticals's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's Days Payable falls into.



GlaxoSmithKline Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

GlaxoSmithKline Pharmaceuticals's Days Payable for the fiscal year that ended in Mar. 2024 is calculated as

Days Payable (A: Mar. 2024 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Mar. 2023 ) + Accounts Payable (A: Mar. 2024 )) / count ) / Cost of Goods Sold (A: Mar. 2024 )*Days in Period
=( (4277.887 + 6254.097) / 2 ) / 14198.485*365
=5265.992 / 14198.485*365
=135.37

GlaxoSmithKline Pharmaceuticals's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (0 + 6254.097) / 1 ) / 4524.485*365 / 4
=6254.097 / 4524.485*365 / 4
=126.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GlaxoSmithKline Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Pharmaceuticals (BOM:500660) Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400 030
GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.

GlaxoSmithKline Pharmaceuticals (BOM:500660) Headlines

No Headlines